Ocular Therapeutix Quarterly Balance Sheets Chart
Quarterly
|
Annual
Ocular Therapeutix Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| assets | |||||||||||||||||||||||||||||||||||||||||||||
| current assets: | |||||||||||||||||||||||||||||||||||||||||||||
| cash and cash equivalents | 391,134,000 | 349,681,000 | 392,102,000 | 427,220,000 | 459,690,000 | 482,888,000 | 195,807,000 | 110,550,000 | 66,606,000 | 79,026,000 | 102,300,000 | 120,950,000 | 134,539,000 | 145,417,000 | 164,164,000 | 179,281,000 | 191,860,000 | 209,378,000 | 228,057,000 | 70,642,000 | 84,294,000 | 48,152,000 | 54,437,000 | 65,414,000 | 61,765,000 | 76,251,000 | 54,062,000 | 56,861,000 | 56,834,000 | 62,911,000 | 51,165,000 | 63,049,000 | 54,682,000 | 52,234,000 | 48,170,000 | 46,212,000 | 30,784,000 | 41,198,000 | 78,686,000 | 12,523,000 | 37,393,000 | 80,892,000 | 19,944,000 | ||
| accounts receivable | 30,412,000 | 25,221,000 | 32,388,000 | 30,235,000 | 30,232,000 | 26,546,000 | 26,179,000 | 23,589,000 | 27,309,000 | 21,124,000 | 21,325,000 | 19,802,000 | 20,482,000 | 23,207,000 | 21,135,000 | 19,552,000 | 18,734,000 | 13,631,000 | 12,252,000 | 7,779,000 | 2,874,000 | 3,429,000 | 2,548,000 | 1,114,000 | 615,000 | 276,000 | 201,000 | 240,000 | 285,000 | 170,000 | 278,000 | 211,000 | 244,000 | 243,000 | 223,000 | 227,000 | 193,000 | 189,000 | 164,000 | 352,000 | 329,000 | 53,000 | 60,000 | ||
| inventory | 3,039,000 | 3,269,000 | 3,040,000 | 2,405,000 | 2,547,000 | 2,574,000 | 2,305,000 | 2,257,000 | 2,204,000 | 2,266,000 | 1,974,000 | 1,545,000 | 1,500,000 | 1,358,000 | 1,250,000 | 1,222,000 | 1,112,000 | 1,123,000 | 1,201,000 | 1,154,000 | 1,067,000 | 1,107,000 | 954,000 | 895,000 | 762,000 | 265,000 | 217,000 | 102,000 | 131,000 | 139,000 | 127,000 | 90,000 | 96,000 | 126,000 | 149,000 | 127,000 | 134,000 | 147,000 | 145,000 | 158,000 | 133,000 | 117,000 | 109,000 | ||
| prepaid expenses and other current assets | 8,790,000 | 9,523,000 | 13,457,000 | 13,151,000 | 6,116,000 | 7,666,000 | 7,794,000 | 4,862,000 | 4,593,000 | 4,746,000 | 4,028,000 | 3,318,000 | 3,801,000 | 4,670,000 | 4,751,000 | 3,877,000 | 4,817,000 | 4,000,000 | 4,650,000 | 2,328,000 | 2,058,000 | 2,465,000 | 2,231,000 | 2,213,000 | 2,294,000 | 2,380,000 | 1,713,000 | 1,071,000 | 1,222,000 | 1,256,000 | 883,000 | 1,978,000 | 2,557,000 | 708,000 | 715,000 | 1,287,000 | 1,592,000 | 1,919,000 | 2,608,000 | 1,537,000 | 893,000 | 1,211,000 | 283,000 | ||
| total current assets | 433,375,000 | 387,694,000 | 440,987,000 | 473,011,000 | 498,585,000 | 519,824,000 | 232,235,000 | 141,258,000 | 100,712,000 | 107,162,000 | 129,627,000 | 145,615,000 | 160,322,000 | 174,652,000 | 191,300,000 | 203,932,000 | 216,523,000 | 228,132,000 | 246,160,000 | 81,903,000 | 90,293,000 | 55,153,000 | 60,170,000 | 69,636,000 | 65,436,000 | 79,172,000 | 56,193,000 | 58,274,000 | 58,472,000 | 64,476,000 | 52,453,000 | 68,328,000 | 83,276,000 | 76,824,000 | 84,974,000 | 97,097,000 | 106,983,000 | 115,898,000 | 126,639,000 | 69,470,000 | 76,183,000 | 82,274,000 | 22,594,000 | ||
| property and equipment | 10,461,000 | 10,784,000 | 9,389,000 | 10,050,000 | 10,887,000 | 11,450,000 | 11,739,000 | 12,494,000 | 12,830,000 | 12,022,000 | 9,856,000 | 7,196,000 | 6,680,000 | 6,614,000 | 6,956,000 | 6,914,000 | 7,042,000 | 7,527,000 | 8,095,000 | 8,490,000 | 8,934,000 | 9,473,000 | 10,151,000 | 10,474,000 | 10,532,000 | 10,548,000 | 10,236,000 | 10,382,000 | 10,373,000 | 10,595,000 | 10,218,000 | 9,619,000 | 5,693,000 | 3,795,000 | 3,199,000 | 3,107,000 | 3,095,000 | 3,193,000 | 2,603,000 | 1,799,000 | 1,782,000 | 1,376,000 | 1,152,000 | ||
| restricted cash | 1,614,000 | 1,614,000 | 150,000 | 150,000 | 1,764,000 | 1,764,000 | 1,764,000 | 1,764,000 | 1,764,000 | 1,764,000 | 1,764,000 | 1,764,000 | 1,764,000 | 1,764,000 | 1,764,000 | 1,764,000 | 1,764,000 | 1,764,000 | 1,764,000 | 1,764,000 | 1,764,000 | 6,764,000 | 6,614,000 | 6,614,000 | 1,614,000 | 1,614,000 | 1,614,000 | 1,728,000 | 1,728,000 | 1,728,000 | 1,728,000 | 1,728,000 | 228,000 | 228,000 | 228,000 | 228,000 | 228,000 | 228,000 | 228,000 | 228,000 | |||||
| operating lease assets | 5,883,000 | 5,828,000 | 5,945,000 | 5,694,000 | 6,005,000 | 6,059,000 | 6,472,000 | 6,868,000 | 7,252,000 | 7,625,000 | 8,042,000 | 4,004,000 | 4,305,000 | 4,592,000 | 4,867,000 | 5,129,000 | 5,378,000 | 5,617,000 | 5,844,000 | 6,062,000 | 6,269,000 | 6,467,000 | 6,655,000 | 6,836,000 | 7,010,000 | 5,156,000 | |||||||||||||||||||
| total assets | 451,333,000 | 405,920,000 | 457,935,000 | 490,369,000 | 517,091,000 | 538,947,000 | 252,060,000 | 162,384,000 | 122,558,000 | 128,573,000 | 149,289,000 | 158,579,000 | 173,071,000 | 187,622,000 | 204,887,000 | 217,739,000 | 230,707,000 | 243,040,000 | 261,863,000 | 98,219,000 | 107,260,000 | 72,857,000 | 78,740,000 | 88,710,000 | 89,742,000 | 101,490,000 | 73,043,000 | 70,270,000 | 70,459,000 | 76,685,000 | 55,431,000 | 64,399,000 | 79,675,000 | 90,697,000 | 74,939,000 | 82,347,000 | 89,901,000 | 100,432,000 | 110,306,000 | 119,319,000 | 129,470,000 | 71,497,000 | 78,193,000 | 83,878,000 | 23,974,000 |
| liabilities and stockholders’ equity | |||||||||||||||||||||||||||||||||||||||||||||
| current liabilities: | |||||||||||||||||||||||||||||||||||||||||||||
| accounts payable | 5,889,000 | 4,626,000 | 4,176,000 | 4,001,000 | 3,689,000 | 6,453,000 | 4,389,000 | 3,984,000 | 3,572,000 | 5,441,000 | 5,123,000 | 5,308,000 | 3,703,000 | 3,420,000 | 4,592,000 | 4,246,000 | 3,881,000 | 4,152,000 | 2,709,000 | 3,238,000 | 2,650,000 | 2,839,000 | 3,268,000 | 3,461,000 | 4,044,000 | 3,902,000 | 2,965,000 | 2,777,000 | 2,137,000 | 3,477,000 | 2,599,000 | 6,307,000 | 3,754,000 | 1,680,000 | 1,611,000 | 2,063,000 | 1,957,000 | 1,624,000 | 2,812,000 | 2,195,000 | 1,316,000 | 649,000 | 1,525,000 | ||
| accrued expenses and other current liabilities | 34,417,000 | 31,080,000 | 35,117,000 | 30,451,000 | 24,358,000 | 16,040,000 | 28,666,000 | 28,887,000 | 24,598,000 | 21,993,000 | 24,097,000 | 21,614,000 | 19,450,000 | 17,636,000 | 20,121,000 | 19,358,000 | 16,182,000 | 13,574,000 | 14,307,000 | 12,165,000 | 5,769,000 | 5,018,000 | 7,635,000 | 6,471,000 | 5,059,000 | 4,037,000 | |||||||||||||||||||
| deferred revenue | 64,000 | 128,000 | 190,000 | 269,000 | 263,000 | 255,000 | 317,000 | 391,000 | 463,000 | 576,000 | 603,000 | 1,189,000 | 1,208,000 | 13,000,000 | 12,000,000 | 12,000,000 | 12,000,000 | 12,000,000 | 42,000 | 83,000 | 125,000 | 250,000 | 188,000 | 250,000 | 250,000 | ||||||||||||||||||||
| operating lease liabilities | 2,625,000 | 2,156,000 | 1,933,000 | 1,717,000 | 1,656,000 | 1,542,000 | 1,586,000 | 1,878,000 | 1,713,000 | 1,818,000 | 1,599,000 | 1,744,000 | 1,771,000 | 1,696,000 | 1,624,000 | 1,554,000 | 1,487,000 | 1,421,000 | 1,358,000 | 1,297,000 | 1,238,000 | 1,181,000 | 1,126,000 | 1,073,000 | 1,024,000 | 675,000 | |||||||||||||||||||
| total current liabilities | 42,931,000 | 37,926,000 | 41,354,000 | 36,359,000 | 29,972,000 | 24,298,000 | 34,896,000 | 35,066,000 | 32,357,000 | 29,715,000 | 31,395,000 | 29,269,000 | 26,113,000 | 23,960,000 | 26,337,000 | 25,158,000 | 21,550,000 | 27,437,000 | 26,664,000 | 22,906,000 | 13,803,000 | 11,112,000 | 12,029,000 | 11,005,000 | 10,127,000 | 8,614,000 | 9,159,000 | 13,406,000 | 11,899,000 | 13,151,000 | 10,945,000 | 13,130,000 | 8,656,000 | 8,243,000 | 6,419,000 | 6,003,000 | 5,378,000 | 11,181,000 | 9,591,000 | 7,227,000 | 5,874,000 | 3,379,000 | 4,489,000 | ||
| other liabilities: | |||||||||||||||||||||||||||||||||||||||||||||
| operating lease liabilities, net of current portion | 4,408,000 | 4,866,000 | 5,345,000 | 5,592,000 | 6,100,000 | 6,407,000 | 6,878,000 | 7,251,000 | 7,689,000 | 8,114,000 | 8,678,000 | 4,610,000 | 4,999,000 | 5,472,000 | 5,924,000 | 6,355,000 | 6,770,000 | 7,169,000 | 7,548,000 | 7,909,000 | 8,256,000 | 8,590,000 | 8,905,000 | 9,206,000 | 9,493,000 | 7,909,000 | |||||||||||||||||||
| derivative liability | 14,024,000 | 13,852,000 | 11,783,000 | 12,914,000 | 6,351,000 | 11,594,000 | 10,461,000 | 13,234,000 | 20,192,000 | 36,064,000 | 59,901,000 | 73,297,000 | 98,313,000 | 28,764,000 | 32,535,000 | 15,528,000 | 12,124,000 | 9,100,000 | 13,068,000 | 11,462,000 | |||||||||||||||||||||||||
| deferred revenue, net of current portion | 14,000,000 | 14,000,000 | 14,000,000 | 14,000,000 | 14,000,000 | 14,068,000 | 14,135,000 | 14,197,000 | 14,254,000 | 13,340,000 | 13,387,000 | 13,533,000 | 13,000,000 | 13,103,000 | |||||||||||||||||||||||||||||||
| notes payable | 69,906,000 | 69,202,000 | 68,505,000 | 67,815,000 | 67,132,000 | 66,456,000 | 65,787,000 | 65,124,000 | |||||||||||||||||||||||||||||||||||||
| other non-current liabilities | 148,000 | 144,000 | 141,000 | 117,000 | 114,000 | 111,000 | 108,000 | 106,000 | 104,000 | 100,000 | 93,000 | ||||||||||||||||||||||||||||||||||
| total liabilities | 145,417,000 | 139,990,000 | 142,591,000 | 138,348,000 | 139,396,000 | 130,964,000 | 160,929,000 | 154,531,000 | 119,471,000 | 118,862,000 | 113,910,000 | 112,350,000 | 107,268,000 | 107,827,000 | 116,888,000 | 130,399,000 | 150,460,000 | 159,632,000 | 185,768,000 | 102,345,000 | 101,916,000 | 83,516,000 | 82,370,000 | 77,409,000 | 81,484,000 | 75,842,000 | 37,168,000 | 24,753,000 | 24,730,000 | 27,501,000 | 28,477,000 | 31,650,000 | 26,792,000 | 20,053,000 | 19,453,000 | 20,262,000 | 20,718,000 | 20,511,000 | 20,358,000 | 19,424,000 | 19,497,000 | 18,276,000 | 19,054,000 | ||
| commitments and contingencies | |||||||||||||||||||||||||||||||||||||||||||||
| stockholders’ equity: | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value; 5,000,000 shares authorized and no shares issued or outstanding at june 30, 2025 and december 31, 2024, respectively | |||||||||||||||||||||||||||||||||||||||||||||
| common stock | 17,000 | 16,000 | 16,000 | 16,000 | 16,000 | 15,000 | 12,000 | 8,000 | 8,000 | 8,000 | 8,000 | 8,000 | 8,000 | 8,000 | 8,000 | 8,000 | 8,000 | 8,000 | 8,000 | 6,000 | 6,000 | 5,000 | 5,000 | 5,000 | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 | 3,000 | 3,000 | 3,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | |||
| additional paid-in capital | 1,328,850,000 | 1,221,051,000 | 1,206,412,000 | 1,194,701,000 | 1,183,882,000 | 1,170,394,000 | 788,697,000 | 676,203,000 | 670,921,000 | 656,863,000 | 652,213,000 | 647,521,000 | 642,907,000 | 638,133,000 | 633,795,000 | 629,286,000 | 624,850,000 | 619,530,000 | 615,338,000 | 449,507,000 | 447,033,000 | 394,463,000 | 379,980,000 | 368,894,000 | 347,074,000 | 340,011,000 | 333,114,000 | 325,357,000 | 310,559,000 | 300,210,000 | 260,082,000 | 256,618,000 | 253,813,000 | 223,344,000 | 221,897,000 | 220,184,000 | 218,830,000 | 217,361,000 | 216,133,000 | 149,077,000 | 148,122,000 | 147,074,000 | 4,745,000 | ||
| accumulated deficit | -1,022,951,000 | -955,137,000 | -891,084,000 | -842,696,000 | -806,203,000 | -762,426,000 | -697,578,000 | -668,358,000 | -667,842,000 | -647,160,000 | -616,842,000 | -601,300,000 | -577,112,000 | -558,346,000 | -545,804,000 | -541,954,000 | -544,611,000 | -536,130,000 | -539,251,000 | -453,639,000 | -441,695,000 | -405,127,000 | -383,615,000 | -357,598,000 | -338,820,000 | -314,367,000 | -297,243,000 | -279,844,000 | -264,834,000 | -251,030,000 | -224,163,000 | -208,596,000 | -189,902,000 | -161,057,000 | -151,461,000 | -140,016,000 | -129,176,000 | -118,539,000 | -107,015,000 | -97,006,000 | -89,428,000 | -81,474,000 | -74,180,000 | ||
| total stockholders’ equity | 305,916,000 | 265,930,000 | 315,344,000 | 352,021,000 | 377,695,000 | 407,983,000 | 91,131,000 | 7,853,000 | 3,087,000 | 9,711,000 | 35,379,000 | 46,229,000 | 65,803,000 | 79,795,000 | 87,999,000 | 87,340,000 | 80,247,000 | 83,408,000 | 76,095,000 | 5,344,000 | -3,630,000 | 11,301,000 | 8,258,000 | 25,648,000 | 35,875,000 | 45,517,000 | 45,729,000 | 49,184,000 | 26,147,000 | 35,922,000 | 48,025,000 | 63,905,000 | 52,008,000 | 62,294,000 | 70,448,000 | 80,170,000 | 89,588,000 | 98,808,000 | 109,112,000 | 52,073,000 | 58,696,000 | 65,602,000 | |||
| total liabilities and stockholders’ equity | 451,333,000 | 405,920,000 | 457,935,000 | 490,369,000 | 517,091,000 | 538,947,000 | 252,060,000 | 162,384,000 | 122,558,000 | 128,573,000 | 149,289,000 | 158,579,000 | 173,071,000 | 187,622,000 | 204,887,000 | 217,739,000 | 230,707,000 | 243,040,000 | 261,863,000 | 98,219,000 | 107,260,000 | 78,740,000 | 88,710,000 | 89,742,000 | 101,490,000 | 73,043,000 | 70,270,000 | 70,459,000 | 76,685,000 | 64,399,000 | 79,675,000 | 90,697,000 | 82,347,000 | 89,901,000 | 100,432,000 | 110,306,000 | 119,319,000 | 129,470,000 | 71,497,000 | ||||||
| preferred stock, 0.0001 par value; 5,000,000 shares authorized and no shares issued or outstanding at march 31, 2025 and december 31, 2024, respectively | |||||||||||||||||||||||||||||||||||||||||||||
| derivative liabilities | 13,246,000 | 14,465,000 | 22,078,000 | 19,624,000 | 29,987,000 | 24,022,000 | |||||||||||||||||||||||||||||||||||||||
| convertible notes | 9,138,000 | 8,765,000 | 29,981,000 | ||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value; 5,000,000 shares authorized and no shares issued or outstanding at december 31, 2024 and december 31, 2023, respectively | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value; 5,000,000 shares authorized and no shares issued or outstanding at september 30, 2024 and december 31, 2023, respectively | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value; 5,000,000 shares authorized and no shares issued or outstanding at june 30, 2024 and december 31, 2023, respectively | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value; 5,000,000 shares authorized and no shares issued or outstanding at march 31, 2024 and december 31, 2023, respectively | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value; 5,000,000 shares authorized and no shares issued or outstanding at december 31, 2023 and december 31, 2022, respectively | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value; 5,000,000 shares authorized and no shares issued or outstanding at september 30, 2023 and december 31, 2022, respectively | |||||||||||||||||||||||||||||||||||||||||||||
| notes payable, net of discount, current | 2,083,000 | 8,290,000 | 8,290,000 | 6,206,000 | 4,146,000 | 2,074,000 | 6,094,000 | 6,082,000 | 6,071,000 | 3,993,000 | 2,444,000 | 897,000 | 3,772,000 | 2,466,000 | 1,161,000 | 5,883,000 | 4,370,000 | 2,860,000 | 1,354,000 | 1,085,000 | |||||||||||||||||||||||||
| notes payable, net of discount, net of current portion | 23,303,000 | ||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value; 5,000,000 shares authorized and no shares issued or outstanding at june 30, 2023 and december 31, 2022, respectively | |||||||||||||||||||||||||||||||||||||||||||||
| notes payable, net of discount | 25,321,000 | 25,257,000 | 25,192,000 | 25,128,000 | 25,063,000 | 25,000,000 | 24,936,000 | 24,891,000 | 14,907,000 | 16,936,000 | 18,964,000 | 20,970,000 | 22,987,000 | 25,007,000 | 24,952,000 | 24,898,000 | 24,843,000 | ||||||||||||||||||||||||||||
| 2026 convertible notes | 29,358,000 | 28,749,000 | 28,152,000 | 27,567,000 | 26,995,000 | 26,435,000 | 25,886,000 | 25,348,000 | 24,822,000 | 24,307,000 | 23,802,000 | 26,352,000 | 25,299,000 | 24,305,000 | 23,146,000 | 23,898,000 | 23,014,000 | ||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value; 5,000,000 shares authorized and no shares issued or outstanding at march 31, 2023 and december 31, 2022, respectively | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value; 5,000,000 shares authorized and no shares issued or outstanding at december 31, 2022 and december 31, 2021, respectively | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value; 5,000,000 shares authorized and no shares issued or outstanding at september 30, 2022 and december 31, 2021, respectively | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value; 5,000,000 shares authorized and no shares issued or outstanding at june 30, 2022 and december 31, 2021, respectively | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value; 5,000,000 shares authorized and no shares issued or outstanding at march 31, 2022 and december 31, 2021, respectively | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value; 5,000,000 shares authorized and no shares issued or outstanding at december 31, 2021 and december 31, 2020, respectively | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value; 5,000,000 shares authorized and no shares issued or outstanding at september 30, 2021 and december 31, 2020, respectively | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value; 5,000,000 shares authorized and no shares issued or outstanding at june 30, 2021 and december 31, 2020, respectively | |||||||||||||||||||||||||||||||||||||||||||||
| stockholders’ equity | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value; 5,000,000 shares authorized and no shares issued or outstanding at march 31, 2021 and december 31, 2020, respectively | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value; 5,000,000 shares authorized and no shares issued or outstanding at december 31, 2020 and december 31, 2019, respectively | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value; 5,000,000 shares authorized and no shares issued or outstanding at september 30, 2020 and december 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||
| total stockholders’ deficit | -4,126,000 | -10,659,000 | -69,435,000 | ||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value; 5,000,000 shares authorized and no shares issued or outstanding at june 30, 2020 and december 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||
| liabilities and stockholders’ deficit | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value; 5,000,000 shares authorized and no shares issued or outstanding at march 31, 2020 and december 31, 2019, respectively | |||||||||||||||||||||||||||||||||||||||||||||
| total liabilities and stockholders’ deficit | 72,857,000 | ||||||||||||||||||||||||||||||||||||||||||||
| other liabilities | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value; 5,000,000 shares authorized and no shares issued or outstanding at december 31, 2019 and december 31, 2018, respectively | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value; 5,000,000 shares authorized and no shares issued or outstanding at september 30, 2019 and december 31, 2018, respectively | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value; 5,000,000 shares authorized and no shares issued or outstanding at june 30, 2019 and december 31, 2018, respectively | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value; 5,000,000 shares authorized and no shares issued or outstanding at march 31, 2019 and december 31, 2018, respectively | |||||||||||||||||||||||||||||||||||||||||||||
| accrued expenses and deferred rent | 6,194,000 | 4,535,000 | 3,680,000 | 3,603,000 | 4,353,000 | 4,379,000 | 4,005,000 | 2,791,000 | 2,342,000 | 2,779,000 | 3,379,000 | ||||||||||||||||||||||||||||||||||
| deferred rent, long-term | 3,221,000 | 3,274,000 | 3,283,000 | 3,336,000 | 3,608,000 | 3,146,000 | 1,315,000 | 32,000 | 42,000 | 55,000 | 68,000 | 81,000 | 94,000 | 103,000 | 112,000 | 121,000 | 119,000 | ||||||||||||||||||||||||||||
| notes payable, net of discount, long-term | 24,788,000 | 8,073,000 | 9,548,000 | 11,014,000 | 13,924,000 | 15,374,000 | 16,821,000 | 11,778,000 | 12,992,000 | 14,204,000 | 15,272,000 | 9,249,000 | 10,673,000 | 12,094,000 | 13,511,000 | 14,776,000 | 13,594,000 | ||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value; 5,000,000 shares authorized and no shares issued or outstanding at december 31, 2018 and december 31, 2017, respectively | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value; 5,000,000 shares authorized and no shares issued or outstanding at september 30, 2018 and december 31, 2017, respectively | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value; 5,000,000 shares authorized and no shares issued or outstanding at june 30, 2018 and december 31, 2017, respectively | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value; 5,000,000 shares authorized and no shares issued or outstanding at march 31, 2018 and december 31, 2017, respectively | |||||||||||||||||||||||||||||||||||||||||||||
| balance sheet data: | |||||||||||||||||||||||||||||||||||||||||||||
| cash, cash equivalents and marketable securities | 41,538,000 | 68,145,000 | |||||||||||||||||||||||||||||||||||||||||||
| working capital | 29,914,000 | 61,598,000 | |||||||||||||||||||||||||||||||||||||||||||
| preferred stock warrant liability | |||||||||||||||||||||||||||||||||||||||||||||
| long-term debt, net of discount, including current portion | 18,016,000 | 15,643,000 | |||||||||||||||||||||||||||||||||||||||||||
| redeemable convertible preferred stock | 74,355,000 | ||||||||||||||||||||||||||||||||||||||||||||
| marketable securities | 3,000,000 | 25,697,000 | 23,513,000 | 35,717,000 | 49,244,000 | 74,280,000 | 72,445,000 | 45,036,000 | 54,900,000 | 37,435,000 | |||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value; 5,000,000 shares authorized at september 30, 2017 and december 31, 2016; no shares issued or outstanding at september 30, 2017 and december 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||
| accumulated other comprehensive loss | -68,000 | -16,000 | -8,000 | ||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value; 5,000,000 shares authorized at june 30, 2017 and december 31, 2016; no shares issued or outstanding at june 30, 2017 and december 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value; 5,000,000 shares authorized at march 31, 2017 and december 31, 2016; no shares issued or outstanding at march 31, 2017 and december 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value; 5,000,000 shares authorized at september 30, 2016 and december 31, 2015, no shares issued or outstanding at september 30, 2016 and december 31, 2015 | |||||||||||||||||||||||||||||||||||||||||||||
| accumulated other comprehensive income | 5,000 | 10,000 | |||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value; 5,000,000 shares authorized at june 30, 2016 and december 31, 2015, no shares issued or outstanding at june 30, 2016 and december 31, 2015 | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value; 5,000,000 shares authorized at march 31, 2016 and december 31, 2015, no shares issued or outstanding at march 31, 2016 and december 31, 2015 | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value; 5,000,000 shares authorized at december 31, 2015 and 2014; no shares issued or outstanding at december 31, 2015 and 2014 | |||||||||||||||||||||||||||||||||||||||||||||
| accrued expenses | 3,591,000 | 2,284,000 | 1,922,000 | 3,016,000 | 2,480,000 | 1,629,000 | |||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value; 5,000,000 authorized at september 30, 2015 and december 31, 2014, no shares issued or outstanding at september 30, 2015 and december 31, 2014 | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value; 5,000,000 authorized at june 30, 2015 and december 31, 2014, no shares issued or outstanding at june 30, 2015 and december 31, 2014 | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value; 5,000,000 authorized at march 31, 2015 and december 31, 2014, no shares issued or outstanding at march 31, 2015 and december 31, 2014 | |||||||||||||||||||||||||||||||||||||||||||||
| accounts receivable from related party | 1,000 | 1,000 | |||||||||||||||||||||||||||||||||||||||||||
| liabilities, redeemable convertible preferred stock and stockholders’ equity | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock warrants | 852,000 | ||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value; 5,000,000 and no shares authorized at december 31, 2014 and 2013, respectively; no shares issued or outstanding at december 31, 2014 and 2013 | |||||||||||||||||||||||||||||||||||||||||||||
| total liabilities, redeemable convertible preferred stock and stockholders’ equity | 78,193,000 | 83,878,000 | |||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value; 5,000,000 and no shares authorized at september 30, 2014 and december 31, 2013, respectively; no shares issued or outstanding at september 30, 2014 and december 31, 2013 | |||||||||||||||||||||||||||||||||||||||||||||
| deferred offering costs | 2,197,000 | ||||||||||||||||||||||||||||||||||||||||||||
| liabilities, redeemable convertible preferred stock and stockholders’ deficit | |||||||||||||||||||||||||||||||||||||||||||||
| stockholders’ deficit: | |||||||||||||||||||||||||||||||||||||||||||||
| total liabilities, redeemable convertible preferred stock and stockholders’ deficit | 23,974,000 | ||||||||||||||||||||||||||||||||||||||||||||
| revenue | 97,000 | ||||||||||||||||||||||||||||||||||||||||||||
| operating expenses: | |||||||||||||||||||||||||||||||||||||||||||||
| cost of revenue | 20,000 | ||||||||||||||||||||||||||||||||||||||||||||
| research and development | 4,292,000 | ||||||||||||||||||||||||||||||||||||||||||||
| selling and marketing | 535,000 | ||||||||||||||||||||||||||||||||||||||||||||
| general and administrative | 1,196,000 | ||||||||||||||||||||||||||||||||||||||||||||
| total operating expenses | 6,043,000 | ||||||||||||||||||||||||||||||||||||||||||||
| income from operations | -5,946,000 | ||||||||||||||||||||||||||||||||||||||||||||
| other income: | |||||||||||||||||||||||||||||||||||||||||||||
| interest income | 1,000 | ||||||||||||||||||||||||||||||||||||||||||||
| interest expense | -257,000 | ||||||||||||||||||||||||||||||||||||||||||||
| other income | -190,000 | ||||||||||||||||||||||||||||||||||||||||||||
| total other income | -446,000 | ||||||||||||||||||||||||||||||||||||||||||||
| net income and comprehensive loss | -6,392,000 | ||||||||||||||||||||||||||||||||||||||||||||
| accretion of redeemable convertible preferred stock to redemption value | -5,000 | ||||||||||||||||||||||||||||||||||||||||||||
| net income attributable to common stockholders | -6,397,000 | ||||||||||||||||||||||||||||||||||||||||||||
| net income per share | -2,100 | ||||||||||||||||||||||||||||||||||||||||||||
| weighted-average common shares outstanding, basic and diluted | 3,044,605,000 |
We provide you with 20 years of balance sheets for Ocular Therapeutix stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Ocular Therapeutix. Explore the full financial landscape of Ocular Therapeutix stock with our expertly curated balance sheets.
The information provided in this report about Ocular Therapeutix stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.